Sponsors and contract research organizations (CROs) fight a continuous uphill battle to reduce complexity, streamline business processes and workflows, ensure compliance and increase efficiencies in the pursuit of bringing drugs to market. Fundamental to this goal is a site-centric approach to conducting clinical trials.
Sites are dynamic environments, and new technology and industry initiatives are important complements to the critical need for relationship-building and maintenance. But, are these technologies and initiatives helping improve site and sponsor-CRO collaboration and creating a competitive edge through improved clinical trial performance?
To explore these issues and their impact, the Society for Clinical Research Sites (SCRS) and Oracle Health Sciences surveyed clinical research site professionals around the world.
The research provided valuable insights into the perceived and actual benefits and challenges for sites related to technology used in clinical trials, site networks and the industry move along the continuum from traditional to hybrid studies.